Join us at #ASN in Houston! We’re excited to be at the American Society of Nephrology’s Kidney Week — and we’d love to meet you! Stop by Booth #1703 and discover the Paradise™ Ultrasound Renal Denervation Procedure —a novel approach designed to help manage hypertension in

Thank you to our incredible faculty for an outstanding session at hashtag#TCT2025! Paradise™ Ultrasound RDN: Real Data. Real Durability. Real Difference A special thank you to Dr. Naomi Fisher & Dr. Ajay Kirtane, who masterfully moderated the session and guided a

Sustained SBP reduction at 24 months! We are grateful to Dr. Ajay J. Kirtane for presenting compelling new evidence from the 24th Radiance pooled analysis showing sustained SBP reductions with Paradise™ uRDN at 2 years with positive safety profile in patients with uncontrolled

First real-world evidence! First look of ongoing EMEA GPS data demonstrated blood pressure reduction. Thank you, Dr. Karl Fengler, for sharing the initial prospective analysis from EMEA GPS registry with Paradise uRDN, showing office SBP reduction of – 19.6mmHg at 6 month

BP-lowering effect after adjusting for medication changes. Thank you, Dr. @JoostDaemen, for presenting new insights at TCT showing that the blood pressure–lowering efficacy of Paradise uRDN in patients with resistant hypertension (Radiance-HTN trio study) was maintained—and

A big thank you to Dr. Roland E. Schmieder for presenting at TCT from his investigator initiated RDN-ADPKD study suggesting systolic and diastolic BP reductions at 3 months following uRDN in patients with ADPKD and uncontrolled hypertension. *Not approved for this indication.

The fog has cleared, and we are now at TCT 2025! Join us TODAY and catch all the Paradise™ Ultrasound RDN sessions-where evidence meets experience. Click now to see Recor’s TCT Scientific Sessions and add them to your calendar: https://t.co/rXLDVPUD3z Stop by Booth #2035 to

Clear the Fog: Join us at #TCT25 and catch all the Paradise™ Ultrasound RDN sessions at TCT 2025-where evidence meets experience. Click now to see Recor’s TCT Scientific Sessions and add them to your calendar: https://t.co/rXLDVPUD3z Stop by Booth #2035 to experience the

Clear the Fog: Join us at #TCT25 and catch all the Paradise™ Ultrasound RDN sessions at TCT 2025-where evidence meets experience. Click now to see Recor’s TCT Scientific Sessions and add them to your calendar: https://t.co/rXLDVPUD3z Stop by Booth #2035 to experience the

Our CMO shares why he’s excited for TCT 2025—and why you should be too. Join us to hear the newest Paradise™ Ultrasound RDN data, connect with peers, and see what’s next in hypertension management. Click now to see Recor’s TCT Scientific Sessions and add them to your calendar:

Please join us for a Webinar led by Dr. Vijay Iyer & Adele Whitted, NP from Buffalo General Medical Center, Gates Vascular Institute. This webinar will provide an in-depth discussion on the new ACC/AHA guidelines and the impact on patient selection in clinical practice, as well

Heading to TCT? Our CMO, Dr. Shon Chakrabarti, invites you to stop by our sessions and booth to catch the latest on Paradise™ Ultrasound RDN—real data, real-world insights, and great conversations with colleagues. Click now to see Recor’s TCT Scientific Sessions and add them

#ParadiseURDN

Clear the Fog: Join us at #TCT25 and catch all the Paradise™ Ultrasound RDN sessions at TCT 2025-where evidence meets experience. Click now to see Recor’s TCT Scientific Sessions and add them to your calendar: https://t.co/1aE9NH1z4x Prescription only. Results may vary.

#hypertension #ParadiseURDN

#hypertension

🫀 New hypertension guidelines = smarter, personalized care. Build treatment plans that fit your patient—not the average. Learn more → https://t.co/MySdZFZddM

Clear the Fog: Join us at #TCT25 and catch all the Paradise™ Ultrasound RDN sessions at TCT 2025-where evidence meets experience. Click now to see Recor’s TCT Scientific Sessions and add them to your calendar: https://t.co/rXLDVPUD3z #Hypertension #ParadiseURDN

References: 1. Kirtane A. et al. JAMA Cardiol. 2023;8(5):464-473 2. Azizi M. et al. Lancet. 2018 Jun ;391(10137):2335-2345. 3. Azizi M. et al. Lancet. 2021 Jun 26;397(10293):2476-2486. 4. Azizi M. JAMA. 2023;329(8):651-661

Drive to Blood Pressure Goal Paradise™ Ultrasound RDN procedure treats hypertension by calming the overactive renal nerves. When medications and lifestyle changes are not enough, it delivers safe and sustained reductions proven across multiple sham-controlled trials. (1-4)